Cover Image

Clinical development update: 1st dengue vaccine candidate

Saved in:

Bibliographic Details
Main Author:	Alain Bouckenooghe (Author)
Format:	Book
Published:	Elsevier, 2016-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessing the potential of a candidate dengue vaccine with mathematical modeling.
by: WHO-VMI Dengue Vaccine Modeling Group, et al.
Published: (2012)

Preparing for dengue vaccine introduction: recommendations from the 1st dengue v2V International Meeting.
by: Joseph Torresi, et al.
Published: (2013)

Aiming at the heart: the capsid protein of dengue virus as a vaccine candidate
by: Laura Lazo, et al.
Published: (2019)

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
by: Alain Bouckenooghe, et al.
Published: (2019)

An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19
by: G.S.N. Koteswara Rao, et al.
Published: (2021)

Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial.
by: Joshua Nealon, et al.
Published: (2016)

Ebola vaccines in clinical trial: The promising candidates
by: Yuxiao Wang, et al.
Published: (2017)

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial
by: Mark Turner, et al.
Published: (2020)

Dengue guidelines - Is it time for an update?
by: Vijai Williams
Published: (2021)

Update on Campylobacter vaccine development
by: Frédéric Poly, et al.
Published: (2019)

An update on Zika vaccine developments
by: Anna Durbin, et al.
Published: (2017)

Clinical and prognostic relevance of sST2 in adults with dengue-associated cardiac impairment and severe dengue.
by: Andrew Teo, et al.
Published: (2022)

COVID-19 vaccine candidates and vaccine development platforms available worldwide
by: Nilgun Duman, et al.
Published: (2021)

Dengue outbreak update in India: 2022
by: Nitin Singh, et al.
Published: (2023)

Dengue overview: An updated systemic review
by: Muhammad Bilal Khan, et al.
Published: (2023)

Prospects for the Development of a Dengue Vaccine
by: Usa Thisyakorn, et al.
Published: (2016)

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions
by: Philippe Moris, et al.
Published: (2019)

SARS-CoV-2 vaccine candidates in rapid development
by: Lifeng Li, et al.
Published: (2021)

Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates.
by: Fiona R Strouts, et al.
Published: (2016)

Major HIV vaccine candidates
by: Wojciech Zdziennicki, et al.
Published: (2023)

Vaccines licensed and in clinical trials for the prevention of dengue
by: J. Torresi, et al.
Published: (2017)

Formulation development of a stable influenza recombinant neuraminidase vaccine candidate
by: Bing Li, et al.
Published: (2024)

Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series
by: Juliana Park, et al.
Published: (2020)

An Update on Pentacyclic Triterpenoids Ursolic and Oleanolic Acids and Related Derivatives as Anticancer Candidates
by: Diana Similie, et al.
Published: (2024)

Zika virus-an update on the current efforts for vaccine development
by: Victória Alves Santos Lunardelli, et al.
Published: (2021)

Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B
by: Dan-Yang Shi, et al.
Published: (2019)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
by: Philippe Moris, et al.
Published: (2018)

Nanoparticles in the clinic: An update post COVID‐19 vaccines
by: Aaron C. Anselmo, et al.
Published: (2021)

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
by: Ngoc Huu Tran, et al.
Published: (2019)

Dengue virus serotype distribution based on serological evidence in pediatric urban population in Indonesia.
by: R Tedjo Sasmono, et al.
Published: (2018)

A Proteomic Approach Identifies Candidate Early Biomarkers to Predict Severe Dengue in Children.
by: Dang My Nhi, et al.
Published: (2016)

Update and New Insights on Future Cancer Drug Candidates From Plant-Based Alkaloids
by: Mounir Tilaoui, et al.
Published: (2021)

Epidemiological update on the dengue situation in the Western Pacific Region, 2012
by: Yuzo Arima, et al.
Published: (2015)

Epidemiologic update on the dengue situation in the Western Pacific Region, 2010
by: Yuzo Arima, et al.
Published: (2011)

Epidemiologic update on the dengue situation in the Western Pacific Region, 2011
by: Tamano Matsui, et al.
Published: (2013)

Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model
by: Mellissa Gomez, et al.
Published: (2022)

Cyclic Di-Adenosine Monophosphate: A Promising Adjuvant Candidate for the Development of Neonatal Vaccines
by: Darío Lirussi, et al.
Published: (2021)

Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease
by: Chih-Yeu Fang, et al.
Published: (2018)

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
by: Vianney Tricou, et al.
Published: (2023)

Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus
by: Shiyang Ma, et al.
Published: (2024)